HOOKIPA Pharma Inc. Research And Development Expense

Quick Answer

HOOKIPA Pharma Inc. reported Research And Development Expense of $68.51 million for the year ending 2024.

  • HOOKIPA Pharma Inc. showed a decrease of -20.7% in Research And Development Expense from 2023 to 2024.
  • This data is from HOOKIPA Pharma Inc.'s annual report (Form 10-K), filed with the SEC on February 28, 2025.
  • XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2017 to 2024), HOOKIPA Pharma Inc.'s Research And Development Expense has grown by 601.1%.
  • Historical annual values: Fiscal year 2024: $68.51 million | Fiscal year 2023: $86.42 million | Fiscal year 2022: $68.65 million | Fiscal year 2021: $82.85 million | Fiscal year 2020: $54.79 million | Fiscal year 2019: $46.31 million | Fiscal year 2018: $21.97 million | Fiscal year 2017: $9.77 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: